Hexa-D-arginine treatment increases 7B2•PC2 activity inhyp-mouse osteoblasts and rescues theHYPphenotype

Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas

(2011) Anke Waha et al.   INTERNATIONAL JOURNAL OF CANCER

Failure to Process Dentin Matrix Protein 1 (DMP1) into Fragments Leads to Its Loss of Function in Osteogenesis

(2010) Yao Sun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa c-terminal fragment

(2010) Yongbo Lu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Ablation of theGalnt3Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite IncreasedFgf23Expression

(2009) Shoji Ichikawa et al.   ENDOCRINOLOGY

Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

(2009) Teruyo Nakatani et al.   FASEB JOURNAL

Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*

(2009) Yukiko Aono et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

(2009) R. Goetz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis

(2008) Holly J. Garringer et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Overexpression of Scg5 increases enzymatic activity of PCSK2 and is inversely correlated with body weight in congenic mice

(2008) Charles R Farber et al.   BMC GENETICS

Studies of the DMP1 57-kDa Functional Domain both in vivo and in vitro

(2008) Yongbo Lu et al.   CELLS TISSUES ORGANS

Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23

(2008) Yuji Yamazaki et al.   JOURNAL OF BONE AND MINERAL RESEARCH